Table 1.
Agent | Dose | Reference |
---|---|---|
SB-334867 | 3-μg/side, i.c. | Hollander et al., 2008; Espana et al., 2010; Plaza-Zabala et al., 2012; Lei et al., 2016b |
Muscimol/baclofen | 50 ng/side for each, i.c. | Chaudhri et al., 2010; Millan et al., 2010; Wilden et al., 2014 |
Baclofen | 1, 5 mg/kg, i.p. | Crabbe et al., 2017 |
Chelerythrine | 0.03–0.4 μg/side, i.c. | Cervo et al., 1997; Narita et al., 2004 |
SCH23390 | 0.3 mg/kg, i.p. | Pina and Cunningham, 2014 |
OrexinA | 100 pmol/side, i.c. | Thorpe and Kotz, 2005; Mayannavar et al., 2014; Zajo et al., 2016 |
TCS-OX2-29 | 3-μg/side, i.c. | Brown et al., 2013; Qi et al., 2013; Lei et al., 2016b |
AP5 | 0.3 μg/side. i.c. | David et al., 2004; Bergado Acosta et al., 2017 |
i.c., indicates intracranial.